Committee Meeting on Sep 30, 2016
Piramal Enterprises Ltd has informed BSE that a meeting of the Administrative Committee of the Board of Directors of the Company will be held on Friday, September 30, 2016 to consider and approve the issue on private placement basis of Secured Non-Convertible Debentures aggregating to Rs. 500 crores. Pfizer completes sale of 4 products to Piramal Enterprises
In May 2016, the US-based pharma major entered into an agreement with Piramal Enterprises to sell its four products for a total consideration of Rs 110 crores Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aberdeen Asset Management Asia Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Piramal's SFG plans aggressive expansion
The non-real estate lending arm of Piramal Enterprises will provide customized offerings to companies across sectors Completion of transaction on the Purchase of brands from Pfizer Limited
Piramal Enterprises Ltd has informed BSE regarding "Completion of transaction on the Purchase of brands from Pfizer Limited". Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aberdeen Asset Management Asia Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Administrative Committee Meeting on Oct 10, 2016
Piramal Enterprises Ltd has informed BSE that a meeting of the Administrative Committee of the Board of Directors of the Company (Committee), which has been duly empowered, will be held on October 10, 2016, to consider and approve the early redemption of Non - Convertible Debentures (NCDs) issued by the Company, subject to receipt of consent(s) from the relevant holders of the NCDs for such early redemption. At the same meeting the Committee... Outcome of Committee Meeting
Piramal Enterprises Ltd has informed BSE that at its meeting held on September 20, 2016, the duly empowered Committee of Directors has approved a proposal to down-sell a part of the Company's lending portfolio, forming part of its financial services business, to its wholly owned subsidiary Piramal Finance Private Limited, for a net consideration of Rs.1,450 crores. Relevant agreements to give effect to this would be executed.This proposal is expected to be completed by end-October 2016. If we get an offer that we cannot refuse, then we will not hold on to the investment: Ajay Piramal, Piramal Enterprises
Our basics are based on Gita and the concept of trusteeship. So in the Gita it is said we are mere trustees of the wealth that has been given to us and we look after it for the beneficiaries Intimation of Schedule of Analyst / Institutional Investor Meetings
Piramal Enterprises Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".